tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OCGN Stock Latest News

Ocugen’s Clinical Progress and Strategic Positioning Drive Buy Rating and Increased Price Target
RatingsOcugen’s Clinical Progress and Strategic Positioning Drive Buy Rating and Increased Price Target
14d ago
OCGN
Ocugen’s Promising Gene Therapy Progress and Financial Stability Drive Buy Rating
PremiumRatings
Ocugen’s Promising Gene Therapy Progress and Financial Stability Drive Buy Rating
15d ago
OCGN
Ocugen Reports Progress in Gene Therapy Trials Amid Financial Losses
PremiumCompany Announcements
Ocugen Reports Progress in Gene Therapy Trials Amid Financial Losses
15d ago
OCGN
Ocugen Inc. Earnings Call: Gene Therapy Advances Amid Financial Challenges
PremiumCompany Announcements
Ocugen Inc. Earnings Call: Gene Therapy Advances Amid Financial Challenges
16d ago
OCGN
OCGN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
OCGN Earnings this Week: How Will it Perform?
18d ago
OCGN
Ocugen’s Promising Phase 2/3 Trial for Stargardt Disease: A Potential Game-Changer
PremiumCompany AnnouncementsOcugen’s Promising Phase 2/3 Trial for Stargardt Disease: A Potential Game-Changer
25d ago
OCGN
Ocugen’s Phase 3 Gene Therapy Trial: A Potential Game-Changer for Retinitis Pigmentosa
Premium
Company Announcements
Ocugen’s Phase 3 Gene Therapy Trial: A Potential Game-Changer for Retinitis Pigmentosa
25d ago
OCGN
Ocugen’s OCU200 Study: A Potential Game-Changer for Diabetic Macular Edema
Premium
Company Announcements
Ocugen’s OCU200 Study: A Potential Game-Changer for Diabetic Macular Edema
25d ago
OCGN
Ocugen initiated with a Buy at Lucid Capital
PremiumThe Fly
Ocugen initiated with a Buy at Lucid Capital
2M ago
OCGN
Ocugen Faces Merger Termination with Carisma Therapeutics
PremiumCompany Announcements
Ocugen Faces Merger Termination with Carisma Therapeutics
2M ago
8K
OCGN
Ocugen’s Strategic Advancements and Promising Prospects Justify Buy Rating
PremiumRatings
Ocugen’s Strategic Advancements and Promising Prospects Justify Buy Rating
2M ago
OCGN
Ocugen Signs Exclusive License Agreement with Kwangdong
PremiumCompany Announcements
Ocugen Signs Exclusive License Agreement with Kwangdong
2M ago
8K
OCGN
Tesla CEO buys shares, China says Nvidia broke antitrust law: Morning Buzz
PremiumThe FlyTesla CEO buys shares, China says Nvidia broke antitrust law: Morning Buzz
2M ago
MU
UA
Ocugen executes licensing agreement with Kwangdong Pharmaceutical
Premium
The Fly
Ocugen executes licensing agreement with Kwangdong Pharmaceutical
2M ago
OCGN
Ocugen Enters Subscription Agreement with Carisma Therapeutics
Premium
Company Announcements
Ocugen Enters Subscription Agreement with Carisma Therapeutics
3M ago
8K
OCGN
Why Is Carisma Therapeutics Stock (CARM) Up 165% Today?
PremiumMarket News
Why Is Carisma Therapeutics Stock (CARM) Up 165% Today?
3M ago
CARM
OCGN
Ocugen’s Strategic Advancements and Financial Positioning Underpin Buy Rating
PremiumRatings
Ocugen’s Strategic Advancements and Financial Positioning Underpin Buy Rating
3M ago
OCGN
Ocugen reports EMA positive advice for acceptability of OCU410ST
PremiumThe Fly
Ocugen reports EMA positive advice for acceptability of OCU410ST
3M ago
OCGN
Ocugen Announces $20M Securities Purchase Agreement
PremiumCompany Announcements
Ocugen Announces $20M Securities Purchase Agreement
3M ago
8K
OCGN
Ocugen announces $20M registered direct offering of common stock, warrants
PremiumThe FlyOcugen announces $20M registered direct offering of common stock, warrants
3M ago
OCGN
Ocugen’s Growth Potential Highlighted by Pivotal Studies and Strong Financial Position
Premium
Ratings
Ocugen’s Growth Potential Highlighted by Pivotal Studies and Strong Financial Position
4M ago
OCGN
Ocugen Reports Progress in Gene Therapy Trials
Premium
Company Announcements
Ocugen Reports Progress in Gene Therapy Trials
4M ago
OCGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >